NCT03891914View on ClinicalTrials.gov

Prospective Comparison of 18F-choline PET/CT and 18F-FDG PET/CT in the Initial Work-up of Multiple Myeloma

PHASE3CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 12, 2019

Primary Completion Date

January 27, 2023

Study Completion Date

January 31, 2023

Conditions
Myeloma Multiple
Interventions
DRUG

Positron Emission Tomography using 18F-FCH

Positron Emission Tomography imaging coupled with scanner (PET-CT). with the injection of a radiopharmaceutical drug, the 18F-FCH(or fluorocholine) for the detection of bone lesions

DRUG

Positron Emission Tomography using 18F-FDG

Positron Emission Tomography imaging coupled with scanner (PET-CT). with the injection of a radiopharmaceutical drug, the 18F-FDG (or fluorodeoxyglucose) for the detection of bone lesions

Trial Locations (1)

33604

Bordeaux University Hospital - Haut-Lévêque, Pessac

All Listed Sponsors
lead

University Hospital, Bordeaux

OTHER

NCT03891914 - Prospective Comparison of 18F-choline PET/CT and 18F-FDG PET/CT in the Initial Work-up of Multiple Myeloma | Biotech Hunter | Biotech Hunter